We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Eli Lilly
LLY
$1.06T
| $173M | 0.33% |
221,781
-76,672
| -26% | -$59.6M |
|
77
Emcor
EME
$33.6B
| $172M | 0.32% |
322,437
+116,289
| +56% | +$51.3M |
|
78
Intuitive Surgical
ISRG
$130B
| $170M | 0.32% |
313,035
-9,678
| -3% | -$5.06M |
|
79
Vistra
VST
$46.7B
| $169M | 0.32% |
871,520
+481,522
| +123% | +$71.3M |
|
80
Shopify
SHOP
$199B
| $167M | 0.31% |
1,443,505
-4,262
| -0.3% | -$426K |
|
81
British American Tobacco
BTI
$122B
| $165M | 0.31% |
3,476,001
+3,315,589
| +2,067% | +$147M |
|
82
GoDaddy
GDDY
$12.4B
| $164M | 0.31% |
909,518
-88,140
| -9% | -$15.8M |
|
83
HEICO Corp
HEI
$46.9B
| $163M | 0.31% |
495,935
-4,564
| -0.9% | -$1.26M |
|
84
JPMorgan Chase
JPM
$943B
| $162M | 0.3% |
557,654
-76,350
| -12% | -$19.5M |
|
85
Comfort Systems
FIX
$56.5B
| $160M | 0.3% |
297,944
-1,989
| -0.7% | -$866K |
|
86
Wingstop
WING
$2.96B
| $158M | 0.3% |
469,762
-47,025
| -9% | -$13.9M |
|
87
TJX Companies
TJX
$149B
| $155M | 0.29% |
1,257,482
+53,647
| +4% | +$6.8M |
|
88
Realty Income
O
$58.5B
| $154M | 0.29% |
2,669,031
+309,902
| +13% | +$17.5M |
|
89
JD.com
JD
$38.3B
| $149M | 0.28% |
4,551,070
+177,000
| +4% | +$6.04M |
|
90
Cardinal Health
CAH
$54.6B
| $148M | 0.28% |
878,986
+88,345
| +11% | +$13.1M |
|
91
Allison Transmission
ALSN
$10.5B
| $147M | 0.28% |
1,544,799
+406,540
| +36% | +$39.3M |
|
92
Maplebear
CART
$11.6B
| $144M | 0.27% |
3,179,537
+347,153
| +12% | +$15.1M |
|
93
Loar Holdings
LOAR
$6.74B
| $142M | 0.27% |
1,649,069
+512,416
| +45% | +$44.3M |
|
94
Tyler Technologies
TYL
$15.1B
| $141M | 0.26% |
237,134
+15,452
| +7% | +$8.75M |
|
95
TSMC
TSM
$2.21T
| $141M | 0.26% |
620,522
+19,696
| +3% | +$3.65M |
|
96
Progressive
PGR
$126B
| $140M | 0.26% |
524,532
+266,919
| +104% | +$73.2M |
|
97
LyondellBasell Industries
LYB
$20.1B
| $140M | 0.26% |
2,414,745
-2,329,494
| -49% | -$136M |
|
98
Duolingo
DUOL
$6.75B
| $140M | 0.26% |
340,444
+89,061
| +35% | +$39.1M |
|
99
TC Energy
TRP
$64.7B
| $140M | 0.26% |
2,860,729
+28,572
| +1% | +$1.4M |
|
100
GSK
GSK
$101B
| $139M | 0.26% |
3,632,471
+3,494,657
| +2,536% | +$134M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.